abstract |
The invention concerns adult multipotent human stem cells, characterized in that they have: n i) significant telomerase activity, n ii) an HLA Class I negative phenotype, n iii) a normal karyotype, n iv) a capacity to become quiescent, n v) a capacity for self-renewal preserved for at least 130 population doublings. |